Dr. Ben Bikman: How To Reverse Insulin Resistance Through Diet, Exercise, & Sleep
FoundMyFitnessKey Moments
Insulin resistance drives most chronic diseases; reverse it via diet, exercise, and sleep habits.
Key Insights
Insulin resistance is a root cause for myriad chronic diseases, often undetected by normal glucose levels.
Measuring fasting insulin, not just glucose, is crucial for early detection of metabolic issues.
Dietary changes, specifically controlling refined carbohydrates and prioritizing protein and natural fats, are highly effective in reversing insulin resistance.
Exercise, especially strength training, and optimizing sleep significantly improve insulin sensitivity and metabolic health.
Intermittent fasting or time-restricted eating, particularly avoiding late-night meals, can enhance insulin sensitivity.
GLP-1 agonists (like Ozempic) can aid in weight loss and appetite control but may not address underlying habits and carry significant risks, suggesting a micro-dosing and cycling approach for habit change is preferable.
INSULIN RESISTANCE: THE UNDETECTED ROOT CAUSE
Dr. Ben Bikman, a professor of cell biology, posits that insulin resistance is a common root cause for most chronic diseases, including type 2 diabetes, obesity, cardiovascular disease, Alzheimer's, fatty liver disease, and infertility. Unlike the common glucose-centric paradigm in modern clinical care, Bikman highlights that many people can be insulin resistant despite having normal blood glucose levels. This 'cold war' of elevated insulin often goes undetected until glucose levels also rise, leading to a delayed diagnosis of pre-diabetes or type 2 diabetes. Insulin, a peptide hormone, affects every cell in the body, making its dysregulation profoundly impactful.
DIAGNOSING INSULIN RESISTANCE: BEYOND GLUCOSE
The conventional medical approach, focused primarily on glucose, fails to identify insulin resistance in its earliest stages. Fasting insulin levels are a critical biomarker that clinicians should measure. High insulin, even with normal glucose, signals the body's struggle to maintain glucose homeostasis. Beyond blood tests, individuals can look for physical signs like acanthosis nigricans (dark, crinkled skin, especially around the neck) and skin tags, both strong indicators of insulin resistance. Continuous glucose monitors (CGMs) are also valuable for dynamic glucose monitoring, revealing abnormal responses to carbohydrate-heavy meals if glucose levels don't return to normal within two hours.
THE COMPREHENSIVE ROLES OF INSULIN
Insulin's functions extend far beyond blood sugar regulation. It plays a significant role in fat accumulation, directly influencing fat cells to grow by blocking fat breakdown. Elevated insulin is essential for fat storage, and without it, even excess calories are not stored as fat, as evidenced by conditions like diabulimia. Insulin also impacts nitric oxide production, essential for blood vessel dilation, and regulates enzymes involved in hormone conversion, such as testosterone to estrogen. Its systemic influence explains why its resistance can contribute to such a broad array of health problems, affecting cells from the brain to bones.
CAUSES OF INSULIN RESISTANCE: FAST VS. SLOW
Insulin resistance can develop rapidly or slowly. 'Fast' insulin resistance is triggered by acute stressors like elevated cortisol or adrenaline, inflammation (e.g., from illness or autoimmune conditions), and paradoxically, too much insulin itself. These acute causes rapidly induce ceramide biosynthesis, which blocks insulin signaling. 'Slow' insulin resistance develops over years, primarily originating in fat tissue. Ectopic fat accumulation, particularly ceramides rather than triglycerides, plays a crucial role. Ceramides disrupt insulin's ability to signal effectively, contributing to long-term insulin resistance in various tissues.
DIETARY FACTORS AND SATURATED FAT NUANCE
Refined carbohydrates and sugars are primary culprits in promoting high insulin levels and insulin resistance. Saturated fats, while often demonized, have a more nuanced role. In the context of a low-carbohydrate diet, consuming saturated fat does not appear to worsen insulin resistance; circulating saturated fat levels are lower due to reduced de novo lipogenesis by the liver. However, a high-saturated fat diet combined with high carbohydrate intake (the "high-fat, high-carb" combination) is particularly detrimental to metabolic and cardiovascular health, leading to increased insulin resistance and adverse lipoprotein profiles like small, dense LDL particles. The type of carbohydrates also matters: low glycemic load carbs like fruits and vegetables are less problematic than refined starches and sugars.
MEAL FREQUENCY AND TIMING
Frequent eating, especially of high-carb, sugary foods, leads to chronic insulin elevation, perpetuating insulin resistance and hunger. The common advice to eat multiple small meals throughout the day is counterproductive for metabolic health. Instead, fewer meals (two to three per day) with controlled carbohydrates and sufficient protein and fat are recommended. Time-restricted eating, particularly consolidating meals earlier in the day, is beneficial. Avoiding late-night eating or snacking is critically important as it can disrupt sleep due to elevated blood glucose and suppressed melatonin, activating the sympathetic nervous system when the body should be resting. Individuals who are night shift workers are at a higher risk of metabolic dysfunction due to disrupted circadian rhythms.
ENVIRONMENTAL FACTORS AND MEDICATIONS
Beyond diet and lifestyle, environmental toxins and commonly prescribed medications can also contribute to insulin resistance. Studies show that exposure to air pollutants, such as diesel exhaust particles and cigarette smoke, can promote fat cell enlargement and insulin resistance even without caloric excess, though these are considered lower-tier concerns for most people compared to diet and exercise. Certain medications, including statins (which increase type 2 diabetes risk, especially in women) and corticosteroids (which induce weight gain via stress pathways), and atypical antipsychotics, can significantly impair metabolic health and cause weight gain.
EFFECTIVE STRATEGIES FOR REVERSAL
Insulin resistance is reversible, often within 90 days. The primary strategy involves controlling carbohydrate intake by focusing on whole fruits (mindful of sugary ones for diabetics) and vegetables, prioritizing protein, and not fearing natural fats. This dietary approach helps lower insulin levels, leading to metabolic advantages like increased metabolic rate and ketone excretion, which aid weight loss. Integrating regular physical activity, especially strength training, is crucial for building muscle, which is a major glucose consumer. Even short 'exercise snacks' after meals can significantly blunt glucose spikes. Avoiding late-night eating, maintaining a consistent meal schedule, and ensuring adequate sleep are also vital components of a comprehensive reversal strategy.
SUPPLEMENTS AND KETONES
Certain supplements can enhance insulin sensitivity. Berberine is a proven effective agent. Apple cider vinegar, containing acetic acid (a short-chain fatty acid), can reduce hepatic gluconeogenesis and activate AMPK, similar to exercise, improving glucose uptake without insulin. Exogenous ketones, like beta-hydroxybutyrate, are powerful signaling molecules beyond just fuel. They can have satiating effects, aid mitochondrial uncoupling, and have shown benefits in improving metabolic markers in conditions like PCOS, suggesting they can offer metabolic advantages even without strict adherence to a ketogenic diet.
FAT STORAGE AND METABOLIC HEALTH: HYPERPLASIA VS. HYPERTROPHY
Fat cells store fat in two ways: hyperplasia (making more small fat cells) and hypertrophy (existing fat cells growing larger). Hypertrophic fat cells are metabolically problematic; they become insulin resistant (to limit further growth) and pro-inflammatory, releasing cytokines that contribute to systemic inflammation and impaired blood flow. Genetic and ethnic factors influence whether individuals are more prone to hyperplasia or hypertrophy. East Asians, for example, often exhibit more fat cell hypertrophy at lower body weights than Caucasians, leading to higher rates of diabetes despite being leaner. Visceral fat, constrained by the abdominal cavity, primarily grows via hypertrophy, making it particularly dangerous.
THE PERIL OF HYPERTROPHIC FAT CELLS
When fat cells grow excessively large (hypertrophy), they become resistant to insulin's signal to inhibit lipolysis. This leads to a problematic state with both high insulin and high free fatty acids in the blood. Since elevated insulin simultaneously inhibits fat burning, these free fatty acids are shunted into ectopic fat deposition in organs like the liver and pancreas, causing fatty liver and other complications. This spillover of fats, particularly ceramides and palmitate, directly activates inflammatory pathways and further impairs insulin signaling, creating a vicious cycle that accelerates systemic insulin resistance and chronic disease.
GLP-1 AGONISTS: SHORTCUT OR SOLUTION?
GLP-1 agonist drugs, like Ozempic and Wegovy, originally developed for diabetes, are now popular for weight loss. They work by delaying gastric emptying, slowing peristalsis, and activating satiety centers in the brain, leading to reduced food intake. However, concerns exist about the high doses currently used, which can cause significant side effects like persistent nausea, burping, and altered drug absorption. While effective for weight loss, they may not address underlying eating habits, leading to weight regain once discontinued. Dr. Bikman suggests a micro-dosing and cycling approach, using these drugs to help individuals change their habits rather than as a lifelong medication.
GLP-1 DRUGS: RISKS AND RECONSIDERATION
The benefits of GLP-1 agonists, such as reduced cardiovascular events or improved metabolic health, may largely be secondary to weight loss and overall metabolic improvement rather than direct receptor activation on many tissues. Observational studies suggest increased risks of blindness, suicidal behavior, major depression, and anxiety with high-dose GLP-1 usage, raising significant caution. Bikman advocates for using these drugs as a temporary 'crutch' to help 'rewire' eating habits, rather than a permanent solution. The goal should be to cycle off the drug once new, healthier habits have been established, especially given the potential for severe side effects and weight regain upon cessation.
INSULIN: THE CENTRAL PLAYER IN AGING
Insulin plays a profound role in biological aging. Chronically elevated insulin persistently activates mTOR (mammalian target of rapamycin), a pathway associated with accelerated aging when overstimulated. Insulin also strongly inhibits autophagy, a crucial cellular recycling process vital for longevity. While glucose is a partner in crime, insulin's direct effects on mTOR activation and autophagy inhibition are significant. Studies in model organisms like worms have shown that reducing insulin signaling dramatically extends lifespan and healthspan by promoting youthful metabolic states. This highlights insulin as a powerful, controllable lever for influencing longevity.
KEY BIOMARKERS FOR METABOLIC HEALTH AND AGING
To monitor metabolic health and predict biological aging, Dr. Bikman recommends several key biomarkers. Fasting insulin, ideally below six microunits per milliliter, is the most critical and often overlooked marker. The triglyceride-to-HDL ratio (triglycerides divided by HDL cholesterol), with a target of less than 1.5, is an excellent surrogate marker for insulin resistance and cardiovascular risk, often more predictive than LDL cholesterol alone. Lower uric acid levels are also associated with healthier, longer lives. While glucose parameters like A1C are important, these additional markers provide a more comprehensive picture of metabolic health and proactive disease prevention.
Mentioned in This Episode
●Supplements
●Products
●Software & Apps
●Tools
●Books
●Studies Cited
●Concepts
●People Referenced
Insulin Sensitivity & Metabolic Health: Core Strategies
Practical takeaways from this episode
Do This
Avoid This
Common Questions
This happens because the body is producing higher-than-normal levels of insulin to keep glucose in check. Modern clinical care often has a 'glucose-centric' paradigm, meaning insulin levels aren't typically measured, causing early insulin resistance to go undetected until blood glucose also rises.
Topics
Mentioned in this video
An equation still used today to assess metabolic rate based on body size.
Researcher who, with Brett Goodpaster, described the 'athletes paradox' related to muscle fat and insulin resistance.
A plasticizer that has been shown to promote greater fat expansion in the absence of calorie changes.
A supplement widely recognized for its effectiveness in improving insulin sensitivity.
Researcher at NIH who published a report on soybean oil becoming the number one consumed source of fat calories in the human diet.
First author of a study at Minnesota that confirmed findings of high metabolic rate in Type 1 diabetes and its reduction with insulin.
Environmental toxins shown to increase adipocyte hypertrophy and body fat mass even without caloric changes, contributing to insulin resistance.
Medications prescribed for inflammation that can cause rapid weight gain by activating the stress pathway and promoting insulin resistance.
Researcher at UT Southwestern who published papers demonstrating that controlling glucagon excess in Type 1 diabetes could correct hypoglycemia without insulin therapy.
A researcher known for his work on low-carbohydrate diets and their impact on saturated fat metabolism and insulin resistance.
An absolute authority from Denmark who has published multiple papers showing that GLP-1 does not elicit an insulin release in humans.
A type of lipid that, when increased in tissues, can cause robust insulin resistance by blocking the insulin signal.
Platform where Dr. Bikman and partners provide coaching services for metabolic health.
Lipid-lowering medications that can increase the risk of type 2 diabetes by 50% in middle-aged and older women and may harm mitochondria.
Researcher who, with David Kelly, described the 'athletes paradox' related to muscle fat and insulin resistance.
A reality TV show that highlighted the challenges of calorie-restricted diets without addressing underlying metabolic issues, often leading to weight regain.
A study that found differences in GLP-1 response to high-carb meals between lean and obese individuals, suggesting a role in satiety control.
Companion book to 'Why We Get Sick' by Ben Bikman with practical advice for maintaining health.
A supplement mentioned as potentially improving insulin sensitivity.
A device that tracks blood glucose levels continuously, useful for monitoring dynamic glucose changes.
A legendary scientist who created the Benedict equation to assess metabolic rate, and studied metabolism in severe diabetes.
Professor of cell biology at Brigham Young University specializing in metabolic disorders and metabolism.
A GLP-1 agonist drug used for weight loss and type 2 diabetes management, often at higher doses than other GLP-1 activators.
Small, benign skin growths that can indicate insulin resistance, often found around the neck and armpits.
A 'starvation scientist' who conducted studies on prolonged fasting and glucose levels, showing brain resilience with ketones.
Environmental toxins that cause ceramides accumulation, mitochondrial fission, and insulin resistance.
Researcher known for his work on time-restricted eating and circadian rhythm, and the My Circadian Clock app.
Researcher known for her work demonstrating that decreasing insulin signaling in nematode worms can double their lifespan.
Famous endocrinologist after whom the Joslin Diabetes Center is named, collaborated with Benedict on diabetes metabolism.
A short-chain fatty acid (acetic acid) that reduces hepatic gluconeogenesis and stimulates AMPK, improving glucose control and insulin sensitivity.
Book by Ben Bikman discussing the conflicting data across LDL and related metabolic health insights.
A plasticizer that has been shown to promote greater fat expansion in the absence of calorie changes.
A key signaling pathway involved in insulin action, often measured in studies of insulin resistance.
A skin condition characterized by darkened, crinkled skin, often around the neck, indicating insulin resistance.
An enzyme activated by exercise and acetic acid from apple cider vinegar, which promotes glucose uptake into muscle without insulin.
A GLP-1 agonist drug used for weight loss and type 2 diabetes management.
An application used in research to track meal timing and its effects, showing late-night eating can disrupt sleep.
Ketones consumed as a supplement, shown to improve metabolic markers and PCOS outcomes, likely through signaling effects.
Former bodybuilder whose physique is contrasted with modern bodybuilders to illustrate potential effects of insulin misuse.
More from FoundMyFitness
View all 92 summaries
2 minWatch my episode with Dr. Charles Brenner
115 minHow To Boost NAD Levels To Fight Inflammation, Improve Recovery, and Slow Aging
92 minDr. Rhonda Patrick: Maximizing Healthspan with Exercise, Sauna, & Cold Exposure
131 minWhy Vigorous Exercise Is 4–10x More Effective Than Moderate (New Evidence)
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Try Summify free